Advertisement
Loading...

BetaShares - Global Healthcare Currency Hedged ETF

DRUG.AX•ASX
Financial Services
Asset Management - Global
$8.49
$0.07(0.83%)
Australian Market opens in 3h 59m
Advertisement

BetaShares - Global Healthcare Currency Hedged ETF (DRUG.AX) Stock Overview

Explore BetaShares - Global Healthcare Currency Hedged ETF’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap164.7M
P/E RatioN/A
EPS (TTM)$0.32
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$8.13
3 Months$8.58
1 Year Target$8.81

DRUG.AX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BetaShares - Global Healthcare Currency Hedged ETF (DRUG.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.96, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $8.81.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 164.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.83%
5-Day Change
1.56%
1-Month Change
2.66%
3-Month Change
-4.71%
6-Month Change
-3.96%
Year-to-Date (YTD) Change
-3.41%
1-Year Change
12.005%
3-Year Change
10.40%
5-Year Change
13.65%
All-Time (Max) Change
69.46%

Contact Information

https://www.betashares.com.au/fund/global-healthcare-etf-currency-hedged/
61 1300487577
Level 46, 180 George Street, Sydney, NaN, 2000

Company Facts

IPO DateAug 4, 2016
CountryAU
Actively Trading

Frequently Asked Questions